# Assessment of Sublingual Immunotherapy in Children Allergic to House Dust Mites

> **NCT01052610** · PHASE4 · UNKNOWN · sponsor: **Medical University of Lodz** · enrollment: 100 (estimated)

## Conditions studied

- Bronchial Asthma
- Allergic Rhinitis

## Interventions

- **DRUG:** sublingual house dust mites allergen extract
- **DRUG:** placebo in sublingual applicator

## Key facts

- **NCT ID:** NCT01052610
- **Lead sponsor:** Medical University of Lodz
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-06
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2013-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01052610

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01052610, "Assessment of Sublingual Immunotherapy in Children Allergic to House Dust Mites". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01052610. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*